Australian Professional Services Stock News

Wagners Holding Company Limited ( ASX:WGN ) shares have continued their recent momentum with a 27% gain in the last...

Microba Life Sciences Limited's ( ASX:MAP ) price-to-sales (or "P/S") ratio of 2.7x may not look like an appealing...

Amid a week of subdued performance on the Australian market, with futures indicating a modest decline of around 0.5%, investors are navigating cautious sentiment influenced by global economic factors, including significant job cuts in the US and ongoing concerns over AI valuations. In such an environment, dividend stocks can offer a measure of stability and income potential, making them particularly appealing to those looking for reliable returns despite broader market uncertainties.

As the Australian market faces a potential dip of around 0.5% amid global economic concerns and a turbulent week, investors are keenly observing how local indices respond to external pressures like high US job cuts and fluctuating commodity prices. In such uncertain times, stocks with strong insider ownership can offer some reassurance, as they often indicate confidence from those closest to the company's operations and future prospects.

The Australian market is poised for a quiet end to the week, with futures indicating a slight decline of around 0.5%, following a turbulent period influenced by high job cuts in the US and ongoing concerns about AI valuations. Despite these broader market challenges, investors often seek opportunities in lesser-known areas like penny stocks, which can offer affordability and potential growth. Although the term "penny stocks" might seem outdated, it still holds significance as these smaller or...

Alliance Aviation Services Limited recently announced a sharp downgrade to its FY26 earnings outlook, citing higher aircraft purchase and maintenance costs, ongoing supply chain inflation, and an unresolved contract dispute, alongside the immediate resignation of founding Managing Director Scott McMillan and CFO Andrew Evans. The leadership transition, combined with rising cost pressures and internal reviews of business units and capital allocation, marks a pivotal period for the company's...

Artrya (ASX:AYA) is on investors’ radar this week, as anticipation grows ahead of its Q1 2026 earnings call scheduled for October 29, 2025. Market watchers are waiting to see how recent trends translate into results. See our latest analysis for Artrya. Momentum has been building for Artrya, with a 27.6% share price return over the past month and a remarkable 445.2% year-to-date. Over the last twelve months, total shareholder return stands at an impressive 576.0%, highlighting the surge in...

Zip Co (ASX:ZIP) drew attention this week by delivering its strongest-ever financial results. The company revealed record earnings along with operational updates at the 2025 AGM. Improvements in operating margin and growth across its main markets were highlighted. See our latest analysis for Zip Co. Despite Zip Co’s impressive operational progress and standout full-year financial results, the share price has pulled back sharply in recent weeks, with a 28.5% decline over the past month and a...

Santana Minerals Limited has been granted a 25-year mining permit for its Bendigo-Ophir Gold Project in Central Otago, New Zealand, allowing full extraction and processing rights at the Rise & Shine deposit and neighboring areas. This milestone secures a pivotal regulatory step, setting the stage for potential construction and first gold production pending environmental approvals expected by mid-2026. We’ll now explore how obtaining this critical permit may influence Santana Minerals’...

Those holding Genetic Signatures Limited ( ASX:GSS ) shares would be relieved that the share price has rebounded 26% in...

With a price-to-earnings (or "P/E") ratio of 13.5x Suncorp Group Limited ( ASX:SUN ) may be sending bullish signals at...

Key Insights Significant control over African Gold by individual investors implies that the general public has more...

Investors who take an interest in AMA Group Limited ( ASX:AMA ) should definitely note that the Independent...

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Mistakes are...

Macquarie Group (ASX:MQG) released its half-year earnings, posting a 3% profit increase supported by solid banking and asset management performance. However, the growth was overshadowed by misses against market expectations. See our latest analysis for Macquarie Group. Macquarie Group’s shares took a near 7% tumble after earnings missed market forecasts, even as the company posted a 3% profit increase. The market’s response shows how expectations and short-term sentiment can outweigh steady...

James Hardie Industries (ASX:JHX) is in the spotlight as a wave of investor class actions target the company over allegations it concealed weakening demand and inventory challenges in its key North America Fiber Cement segment. These lawsuits come at a turbulent time for shareholders. They have already faced major leadership changes following backlash to the company’s high-profile AZEK acquisition and upcoming removal from the MSCI Australia Index. See our latest analysis for James Hardie...

National Australia Bank (ASX:NAB) just released its full-year results, catching investors’ attention as profits slipped slightly below expectations. The earnings announcement coincided with a drop in NAB’s share price and fueled new questions about its competitive position. See our latest analysis for National Australia Bank. NAB’s latest earnings miss, alongside a steady dividend and growing competition in business banking, has made the recent drop in its share price feel more like a pause...

Earlier this week, Neuren Pharmaceuticals announced record Q3 2025 DAYBUE™ sales of US$101.1 million and provided an updated royalty outlook as Acadia Pharmaceuticals narrowed its full-year U.S. net sales forecast for the Rett syndrome drug. This development highlights both strong demand for DAYBUE and the sensitivity of Neuren's earnings to royalty projections and its partnership with Acadia. We'll now examine how strong DAYBUE sales growth and the revised royalty outlook influence Neuren's...

IPH Limited recently announced that CEO Dr. Andrew Blattman will retire in the second half of 2026, prompting the company to begin a formal search for a new leader from both internal and external candidates. Dr. Blattman’s lengthy tenure saw IPH expand its footprint in Asia and enter the Canadian market, which has helped shape the group’s international presence and long-term direction. We'll examine how the planned CEO transition and leadership search may impact IPH's investment outlook and...

NRW Holdings' (ASX:NWH) stock is up by a considerable 39% over the past three months. However, we decided to pay...

Artrya Limited has announced its upcoming Q1 2026 earnings call, scheduled for October 29, 2025, signaling a key moment for stakeholders awaiting developments from the company. This earnings call has captured increased user attention, reflecting heightened anticipation in the absence of other major company announcements in recent weeks. We'll explore how anticipation around Artrya's upcoming earnings call shapes the company's investment narrative and investor expectations. Explore 27 top...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

With the business potentially at an important milestone, we thought we'd take a closer look at AML3D Limited's...

Nuix Limited ( ASX:NXL ) shares have had a horrible month, losing 33% after a relatively good period beforehand. For...